If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Prognostic impact of C4.4A in non-small cell lung cancer

$48.00 plus tax (Refund Policy)

Download / Buy Article:

Abstract:

C4.4A is a structural homologue of the urokinase-type plasminogen activator receptor (uPAR), which, through its involvement in pathogenic plasminogen activation, is a well-consolidated prognostic marker in a variety of human cancers. Although the biological function of C4.4A remains elusive, the protein has been implicated in cancer invasion and metastasis, possibly playing a role in cell/cell or cell/matrix interactions.

Particularly interesting observations have been made on the expression of C4.4A in non-small cell lung cancer (NSCLC). An immunohistochemical, retrospective study was performed on formalin-fixed, paraffin-embedded specimens from 104 patients, including 56 squamous cell carcinomas (SCC), 40 adenocarcinomas (AC) and 8 large cell carcinomas (LCC). Whereas normal lung tissue was negative for C4.4A, high levels were found in 77 % of SCC, 24 % of AC and 13 % of LCC, thus correlating C4.4A expression to histological type of NSCLC. Staining with a well-characterized polyclonal anti-C4.4A antibody was either confined to invasive areas of the tumor or present in all cancer cells.

Survival data displayed a correlation between high C4.4A expression and overall mortality in NSCLC patients (P=0.012). Intriguingly, a closer examination of these data revealed that the subgroup of patients having high C4.4A expression combined with a histological classification as adenocarcinoma had a particularly poor survival (P < 0.0001), all patients dying within 2 years. This is the first demonstration of a very strong prognostic significance of C4.4A in NSCLC, with a predominant impact on patients with AC. Preliminary data furthermore show that C4.4A might be a marker of premalignant lesions of NSCLC.

Document Type: Abstract

DOI: http://dx.doi.org/10.1111/j.1600-0463.2008.001165_8.x

Affiliations: 1: Patologisk afdeling, Gentofte Hospital, Niels Andersens Vej 65, 2900 Hellerup 2: Finsenlaboratoriet, Rigshospitalet afsnit 3735, Ole Maaløes Vej 5, 2200 København N

Publication date: May 1, 2008

Related content

Tools

Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more